Kevin Culligan is a Shareholder and member of Maynard Cooper’s Intellectual Property Litigation and Intellectual Property Protection practice groups. He has focused his practice for more than 35 years on the litigation, trial, arbitration and appeal of intellectual property matters, concentrating primarily on patent, trade secret and unfair competition cases in the fields of pharmaceuticals, medical devices, biotechnology and financial services. Kevin also has extensive licensing experience, including the development and execution of licensing and enforcement programs involving patent portfolios that include hundreds of patents.

In 2014 and 2016, Kevin was honored as one of the best of the best patent litigators in the country and in 2014 as one of the 30 best practitioners in the field worldwide by The Legal Media Group. He has also been recognized for his patent litigation work by Managing Intellectual Property and IAM, and was named as one of the preeminent life sciences practitioners in North America in Euromoney LMG’s 2012 and 2014 editions of “Life Sciences”.

Kevin is a frequent lecturer on various intellectual property law matters, and he served as a faculty member for organizations that include the Practising Law Institute and the American Conference Institute.

Before joining Maynard Cooper & Gale, Culligan was a partner in Goodwin Procter’s IP Litigation Group, Patent Litigation Practice and FinTech Practice. He earned an A.B. in Biology from Colgate University in 1976 and a J.D. from Cornell Law School in 1980, and was a partner for many years at Fish & Neave before that patent litigation firm merged with another firm in 2005.